stockrowMettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.
- Revenue
- +4.48%
- EPS
- +18.3%
- Free cash flow
- +33.0%
- Total debt
- −3.29%
Quarter to June 2026, against a year earlier
Follow MTD
Alert me
Mettler-Toledo International, Inc. (MTD) Return on invested capital
Mettler-Toledo International, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 35.4%, up 1.5 percentage points from fiscal 2025 (33.9%). Over the past ten years it has ranged from 27.7% (fiscal 2017) to 38.5% (fiscal 2024); the current reading is higher than 64% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 33.9% | (4.63) |
| FY2024 | 38.5% | 2.28 |
| FY2023 | 36.3% | 0.04 |
| FY2022 | 36.2% | 0.79 |
| FY2021 | 35.4% | 3.25 |
| FY2020 | 32.2% | 1.92 |
| FY2019 | 30.3% | 0.75 |
| FY2018 | 29.5% | 1.86 |
| FY2017 | 27.7% | (1.04) |
| FY2016 | 28.7% | (0.55) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 46.0% |
| MTD Mettler-Toledo International, Inc. | 35.4% |
| ILMN Illumina, Inc. compare | 16.7% |
| A Agilent Technologies, Inc. compare | 11.1% |
| DGX Quest Diagnostics Incorporated compare | 8.48% |
| IQV IQVIA Holdings Inc. compare | 6.79% |
| LH Labcorp Holdings Inc. compare | 6.76% |
| WAT Waters Corporation compare | 1.13% |
| GH Guardant Health, Inc. compare | −25.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on MTD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement